The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArcontech Group Regulatory News (ARC)

Share Price Information for Arcontech Group (ARC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 104.00
Bid: 102.00
Ask: 106.00
Change: 0.00 (0.00%)
Spread: 4.00 (3.922%)
Open: 104.00
High: 104.00
Low: 104.00
Prev. Close: 104.00
ARC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

29 Nov 2021 07:00

RNS Number : 7995T
Arcontech Group PLC
29 November 2021
 

ARCONTECH GROUP PLC

 

("Arcontech" or the "Company")

Trading Update

Arcontech (AIM: ARC), the provider of products and services for real-time financial market data processing and trading, announces that its trading performance has regrettably fallen below current market expectations due to one customer reducing its market data spend with the Company, and notification from another customer that it will not be renewing its contract from the start of second half of 2022. The two changes are unrelated and do not involve customers with Arcontech's core MVCS server-side solution. They instead reflect one customer greatly scaling back its market data team and market data requirements, and a second choosing not to renew its contract for one Arcontech product because it is switching to use a solution included in a legacy, bundled contract.

The Company is consequently revising its year end market guidance to reflect this net reduction of revenue. The reductions will take effect at the beginning of the second half of Arcontech's financial year and consequently will negatively impact revenue by annualised c.£300K, half of which will impact in the current financial year.

However, notwithstanding the above the Company senses an overall improvement in the business outlook which until now has seen growth affected by Covid. Its clients are now renewing interest in new business projects and the Company's sales pipeline continues to be healthy. The increasing opportunities to travel and cement new relationships also bode well for the future and our ability to recover lost ground. During the last year Arcontech has improved its offerings to provide more value and the quality of its solutions together with its ability to help reduce spend, positions the Company well to absorb any lost business and resume growth as the pipeline matures. Arcontech continues to be fully confident in the strength of the business and is working to leverage its cash reserves, when the opportunity arises.

Enquiries:

 

Arcontech Group plc

 020 7256 2300

Geoff Wicks, Chairman and Non-Executive Director

Matthew Jeffs, Chief Executive

finnCap Ltd (Nomad & Broker)

Carl Holmes/Tim Harper

 020 7220 0500

To access more information on the Group please visit: www.arcontech.com

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFEFFAAEFSEDF
Date   Source Headline
16th Mar 20204:40 pmRNSSecond Price Monitoring Extn
16th Mar 20204:36 pmRNSPrice Monitoring Extension
5th Mar 20207:00 amRNSInterim Results
28th Feb 20203:28 pmRNSTrading Update & Notice of Results
2nd Dec 20194:20 pmRNSMichael Levy
3rd Oct 20191:28 pmRNSResult of AGM
27th Sep 20191:14 pmRNSGrant of Options
11th Sep 20197:00 amRNSHolding(s) in Company
2nd Sep 20197:00 amRNSPosting of Annual Report & Notice of AGM
22nd Aug 20197:00 amRNSFinal Results
11th Jul 20197:00 amRNSTrading Update and Notice of Results
15th May 20197:00 amRNSDirector/PDMR Shareholding
8th May 20194:21 pmRNSHolding(s) in Company
29th Mar 20192:27 pmRNSDirector/PDMR Shareholding
27th Feb 20197:00 amRNSInterim Results
4th Feb 20197:00 amRNSIncreased client uptake of Excelerator
4th Dec 20189:56 amRNSHolding(s) in Company
3rd Dec 20184:13 pmRNSGrant of Options
27th Sep 201812:20 pmRNSResult of AGM
31st Aug 20187:00 amRNSPosting of Annual Report & Notice of AGM
23rd Aug 20187:00 amRNSFinal Results
13th Jul 20182:47 pmRNSDirector/PDMR Shareholding
10th Jul 20187:00 amRNSTrading Update / Notice of Results
20th Apr 20188:30 amRNSIssue of Equity and Director / PDMR Shareholding
29th Mar 20182:02 pmRNSDirector/PDMR Shareholding
1st Mar 201811:00 amRNSHolding(s) in Company
22nd Feb 20187:00 amRNSHalf-year Report
12th Oct 20173:32 pmRNSIssue of Equity & Director/PDMR Shareholding
27th Sep 20175:23 pmRNSResult of AGM
26th Sep 201711:48 amRNSResult of AGM and Dividend Timetable
22nd Sep 20177:00 amRNSIssue of Equity
25th Aug 20179:20 amRNSPosting of Annual Report & Notice of AGM
24th Aug 201712:28 pmRNSHolding(s) in Company
17th Aug 201711:06 amRNSIssue of Equity & Director/PDMR Shareholding
14th Aug 20177:00 amRNSFinal Results
26th Jul 201711:08 amRNSIssue of Equity
6th Jul 20171:30 pmRNSIssue of Equity
3rd Jul 20174:09 pmRNSIssue of Equity
26th Jun 20171:42 pmRNSDirector Declaration
13th Jun 20177:00 amRNSDirector/PDMR Shareholding
12th Jun 20174:29 pmRNSDirector/PDMR Shareholding
15th May 20177:00 amRNSIssue of Equity
10th May 20174:01 pmRNSDirector/PDMR Shareholding
8th May 20179:47 amRNSIssue of Equity & Director/PDMR Shareholding
4th May 20177:00 amRNSDirector/PDMR Shareholding
26th Apr 20177:00 amRNSGrant of Options and Director/PDMR Shareholdings
9th Mar 20176:05 pmRNSGrant of Options / Director Shareholding
6th Mar 20177:00 amRNSHalf-year Report
9th Dec 201612:22 pmRNSIssue of Equity
6th Dec 201610:06 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.